⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for ef5

Every month we try and update this database with for ef5 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck CancerNCT00049140
Head and Neck C...
EF5
bioluminescence
flow cytometry
immunohistochem...
biopsy
18 Years - Duke University
EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue SarcomaNCT00004261
Breast Cancer
Cervical Cancer
Head and Neck C...
Prostate Cancer
Sarcoma
EF5
flow cytometry
fluorescent ant...
immunohistochem...
biopsy
18 Years - 120 YearsUniversity Health Network, Toronto
EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck CancerNCT00049140
Head and Neck C...
EF5
bioluminescence
flow cytometry
immunohistochem...
biopsy
18 Years - Duke University
EF5 in Assessing Tumor Response to Anticancer Therapy in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung CancerNCT00041028
Lung Cancer
EF5
flow cytometry
immunohistochem...
18 Years - National Cancer Institute (NCI)
Efficacy of Hyperbaric Oxygen Therapy in Laryngectomy PatientsNCT00026975
Laryngeal Cance...
Hyperbaric Oxyg...
18 Years - National Center for Complementary and Integrative Health (NCCIH)
Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain TumorsNCT00110032
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Brain Ste...
Adult Central N...
Adult Choroid P...
Adult Craniopha...
Adult Diffuse A...
Adult Ependymob...
Adult Ependymom...
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Adult Grade I M...
Adult Grade II ...
Adult Grade III...
Adult Medullobl...
Adult Meningeal...
Adult Mixed Gli...
Adult Myxopapil...
Adult Oligodend...
Adult Pilocytic...
Adult Pineoblas...
Adult Pineocyto...
Adult Subependy...
Adult Supratent...
Meningeal Melan...
EF5
conventional su...
positron emissi...
fluorine F 18 E...
pharmacological...
18 Years - National Cancer Institute (NCI)
EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung CancerNCT00087191
Advanced Adult ...
Carcinoma of th...
Fallopian Tube ...
Gastrointestina...
Localized Extra...
Localized Gallb...
Localized Gastr...
Localized Resec...
Localized Unres...
Metastatic Gast...
Ovarian Sarcoma
Ovarian Stromal...
Primary Periton...
Recurrent Adult...
Recurrent Adult...
Recurrent Colon...
Recurrent Extra...
Recurrent Gallb...
Recurrent Gastr...
Recurrent Gastr...
Recurrent Non-s...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Pancr...
Recurrent Recta...
Recurrent Small...
Recurrent Uteri...
Regional Gastro...
Small Intestine...
Small Intestine...
Small Intestine...
Stage 0 Non-sma...
Stage I Adult S...
Stage I Colon C...
Stage I Gastric...
Stage I Non-sma...
Stage I Ovarian...
Stage I Ovarian...
Stage I Pancrea...
Stage I Rectal ...
Stage I Uterine...
Stage II Adult ...
Stage II Colon ...
Stage II Gastri...
Stage II Non-sm...
Stage II Ovaria...
Stage II Ovaria...
Stage II Pancre...
Stage II Rectal...
Stage II Uterin...
Stage III Adult...
Stage III Colon...
Stage III Gastr...
Stage III Ovari...
Stage III Ovari...
Stage III Pancr...
Stage III Recta...
Stage III Uteri...
Stage IIIA Non-...
Stage IIIB Non-...
Stage IV Adult ...
Stage IV Colon ...
Stage IV Gastri...
Stage IV Non-sm...
Stage IV Ovaria...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Rectal...
Stage IV Uterin...
Unresectable Ex...
Unresectable Ga...
EF5
motexafin lutet...
pharmacological...
18 Years - National Cancer Institute (NCI)
Imaging and Biomarkers of Hypoxia in Solid TumorsNCT01123005
Neoplasms
PET Scan
EF5
Carbogen
Dichloroacetate
18 Years - Stanford University
Imaging and Biomarkers of Hypoxia in Solid TumorsNCT01123005
Neoplasms
PET Scan
EF5
Carbogen
Dichloroacetate
18 Years - Stanford University
Metabolic Reprogramming Therapy for Treatment of Recurrent Head and Neck CancersNCT01163487
Head and Neck C...
Head and Neck C...
Dichloroacetate
EF5
18 Years - Stanford University
EF5 in Measuring Tumor Hypoxia in Patients With Stage I-III Non-Small Cell Lung CancerNCT02154399
Stage IA Non-Sm...
Stage IB Non-Sm...
Stage IIA Non-S...
Stage IIB Non-S...
Stage IIIA Non-...
Stage IIIB Non-...
EF5
Laboratory Biom...
Therapeutic Con...
Tissue Oxygen M...
18 Years - National Cancer Institute (NCI)
EF5 in Treating Patients With Solid TumorsNCT00003282
Unspecified Adu...
EF5
therapeutic con...
biopsy
pharmacological...
18 Years - National Cancer Institute (NCI)
EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometrial, or Ovarian Epithelial CancerNCT00107445
Primary Periton...
Stage I Endomet...
Stage I Ovarian...
Stage IA Cervic...
Stage IB Cervic...
Stage II Endome...
Stage II Ovaria...
Stage IIA Cervi...
Stage IIB Cervi...
Stage III Cervi...
Stage III Endom...
Stage III Ovari...
Stage IV Endome...
Stage IV Ovaria...
Stage IVA Cervi...
Stage IVB Cervi...
EF5
18 Years - National Cancer Institute (NCI)
EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck CancerNCT00049140
Head and Neck C...
EF5
bioluminescence
flow cytometry
immunohistochem...
biopsy
18 Years - Duke University
EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue SarcomaNCT00004261
Breast Cancer
Cervical Cancer
Head and Neck C...
Prostate Cancer
Sarcoma
EF5
flow cytometry
fluorescent ant...
immunohistochem...
biopsy
18 Years - 120 YearsUniversity Health Network, Toronto
To Evaluate the Characteristics of a Breast CancerNCT01055678
Breast Cancer
EF5
Partial or Tota...
18 Years - Duke University
EF5 to Detect Tumor Hypoxia in Patients With Stage IIB, Stage IIIB, or Stage IVA Cervical CancerNCT00049231
Cervical Cancer
EF5
immunohistochem...
biopsy
18 Years - National Cancer Institute (NCI)
EF5 to Evaluate Tumor Hypoxia in Patients With High-Grade Soft Tissue Sarcoma or Mouth CancerNCT00896961
Stage I Adult S...
Stage I Squamou...
Stage II Adult ...
Stage II Squamo...
Stage III Adult...
Stage III Squam...
EF5
diagnostic labo...
pharmacological...
18 Years - National Cancer Institute (NCI)
EF5 to Evaluate Tumor Hypoxia in Patients With High-Grade Soft Tissue Sarcoma or Mouth CancerNCT00896961
Stage I Adult S...
Stage I Squamou...
Stage II Adult ...
Stage II Squamo...
Stage III Adult...
Stage III Squam...
EF5
diagnostic labo...
pharmacological...
18 Years - National Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: